carmenwong-lab.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.carmenwong-lab.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change
Meta Tags
Title Carmen Wong
Description Carmen Wong Cancer Biology Lab Faculty of Medicine, The University of Hong Carmen Wong HKU Homepage of Dr. Carmen Wong, the University of Hong
Keywords N/A
Server Information
WebSite carmenwong-lab faviconcarmenwong-lab.com
Host IP 185.230.63.107
Location -
Related Websites
Site Rank
More to Explore
carmenwong-lab.com Valuation
US$1,061
Last updated: 2023-05-20 07:05:03

carmenwong-lab.com has Semrush global rank of 0. carmenwong-lab.com has an estimated worth of US$ 1,061, based on its estimated Ads revenue. carmenwong-lab.com receives approximately 122 unique visitors each day. Its web server is located in -, with IP address 185.230.63.107. According to SiteAdvisor, carmenwong-lab.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$1,061
Daily Ads Revenue US$0
Monthly Ads Revenue US$29
Yearly Ads Revenue US$352
Daily Unique Visitors 8
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
carmenwong-lab.com. A 3599 IP: 185.230.63.107
carmenwong-lab.com. A 3599 IP: 185.230.63.186
carmenwong-lab.com. A 3599 IP: 185.230.63.171
carmenwong-lab.com. NS 86400 NS Record: ns6.wixdns.net.
carmenwong-lab.com. NS 86400 NS Record: ns7.wixdns.net.
HtmlToTextCheckTime:2023-05-20 07:05:03
top of page Carmen Wong Cancer Biology Lab Faculty of Medicine, The University of Hong Kong Research People Publications Grants and Awards News 2022+ Album 2023 2022 2021 2020 2019 + Join Us More Use tab to navigate through the menu items. Research Interests Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer. It is the fifth most common and third most lethal cancer worldwide. Most HCC patients present symptoms at advanced stages when they are no longer suitable for surgical treatments. Unfortunately, HCC is resistant to conventional radio- and chemo-therapies. Currently, there are five FDA-approved targeted therapies and two immunotherapies for advanced HCC patients but their effects are only modest. Therefore, knowledge on the molecular biology of HCC is warranted for the development of better diagnostic platforms and therapeutic regimens. Our research focuses on three emerging, fundamental, and inter-related aspects in HCC. Immune microenvironment, immune
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Fri, 20 Jan 2023 09:28:50 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.carmenwong-lab.com/
strict-transport-security: max-age=3600
Age: 9004
Server-Timing: cache;desc=hit, varnish;desc=hit, dc;desc=84
X-Seen-By: qdrMdw4zrP0/E6B8JtgqKA==,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVgS+Hj2MokSER7h+mpPdHRZ,m0j2EEknGIVUW/liY8BLLsTmBPoSPlaywGXfZN3Xgj7JftmKrOReD3ukbbas4YDo,2d58ifebGbosy5xc+FRalh+9qtdUpN5k2rhkOLK6Sb464QiU27Zx3Fo8vBtNM7RgnoSsvJYmKaFVFMhuolrEzA==,2UNV7KOq4oGjA5+PKsX47NkbCs7NWzOa7Lk4dAE/5sG8ZDY613cHYLbuhNMgAom1
Cache-Control: no-cache
X-Wix-Request-Id: 1674206930.02235345749610485
X-Content-Type-Options: nosniff

HTTP/2 200 
content-type: text/html; charset=UTF-8
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
x-wix-request-id: 1674206930.169320606544382
content-language: en
strict-transport-security: max-age=3600
age: 0
accept-ranges: bytes
set-cookie: XSRF-TOKEN=1674206930|fwsJnei4hWFo; Path=/; Domain=www.carmenwong-lab.com; Secure; SameSite=None
set-cookie: ssr-caching=cache#desc=miss#varnish=miss_miss#dc#desc=fastly_g; max-age=20
cache-control: private,max-age=0,must-revalidate
x-content-type-options: nosniff
server: Pepyaka/1.19.10
date: Fri, 20 Jan 2023 09:28:50 GMT
x-served-by: cache-fra-eddf8230104-FRA
x-cache: MISS
vary: Accept-Encoding
server-timing: cache;desc=miss, varnish;desc=miss_miss, dc;desc=fastly_g
x-seen-by: yvSunuo/8ld62ehjr5B7kA==,GXNXSWFXisshliUcwO20NQ1aV/eYQaI5OrqNssi0Z4IwiovsGXaVRtJBbyanlMHS,qquldgcFrj2n046g4RNSVIrig9SAqnXW0O7zAzsQkQs=,2d58ifebGbosy5xc+FRaluce08Jw1QRRE0/A017EZPPzv2b+TQaJxqreMYTL6ckVjoe2GMQJ/MdiMK4Y/vI70wC/kCWSfPJb20DZZ7+Q87U=,2UNV7KOq4oGjA5+PKsX47KUxGpOniMyOzfSS/86iiHlWd3xniMsr1HjrszKGvMzr,7npGRUZHWOtWoP0Si3wDp3pk+fOCkUHYAkRreQULO2E=,m86p0LbwQP79i4nFFg3YpgcFPK/V9A8jXxORjXp/kiIdBxy1+NINubea65+w8itg,xTu8fpDe3EKPsMR1jrheEBi45E/8fJdJ8oWshEMBDoA=,LoUK8/saGAmOxZWtpubo2leTAIKm/bEWaMRniwm9S9xbTKJs3UlO31jeAByv04e8GKFsE8UbFR8ogSZF/8UgwA==,xTu8fpDe3EKPsMR1jrheEENCbwA176DoP3JYix0wLIk=,xTu8fpDe3EKPsMR1jrheEFfOcWBkWWyy4TO0LGr2jQk=,/a5ccLSK1HEmwPNg/x6OuhwVf+M/llv4ecAdPJ9TQifUESScvf2HAnUf3Z88btRfiSefO/WuOb7w0vLixx0/iw==
via: 1.1 google
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"